✦ LIBER ✦

441 THE ITPA GENOTYPE CORRELATES WITH HEMOLYTIC ANEMIA AND OUTCOME AFTER TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN IN GENOTYPE IB CHRONIC HEPATITIS C

✍ Scribed by M. Kurosaki; K. Tanaka; Y. Suzuki; Y. Hoshioka; N. Tamaki; T. Kato; Y. Yasui; T. Hosokawa; K. Ueda; K. Tsuchiya; T. Kuzuya; H. Nakanishi; J. Itakura; Y. Takahashi; Y. Asahina; M. Mizokami; Y. Tanaka; N. Sakamoto; N. Enomoto; N. Izumi

Book ID: 117379586
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 43 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(11)60443-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Model incorporating the ITPA genotype id

Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C

✍ Kurosaki, Masayuki; Tanaka, Yasuhito; Nishida, Nao; Sakamoto, Naoya; Enomoto, No 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

1128 PREDICTION MODEL OF ANEMIA USING IT

1128 PREDICTION MODEL OF ANEMIA USING ITPA GENOTYPE IDENTIFIES PATIENTS AT HIGH RISK OF ANEMIA AND TREATMENT FAILURE WITH PEGYLATED-INTERFERON PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C

✍ Kurosaki, M.; Itakura, J.; Tsuchiya, K.; Nakanishi, H.; Asahina, Y.; Mizokami, M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Interleukin 28B polymorphism predicts pe

Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4

✍ Stella De Nicola; Alessio Aghemo; Maria Grazia Rumi; Enrico Galmozzi; Luca Valen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 1 views

Single nucleotide polymorphisms (SNPs) near the interleukin 28B (IL28B) region are the strongest baseline predictors of a sustained virologic response (SVR) to peg-interferon (PegIFN) and ribavirin (Rbv) in patients with hepatitis C virus (HCV) genotype 1 infection. Whether this holds true for HCV-4

Pegylated interferon-alpha 2b–ribavirin

Pegylated interferon-alpha 2b–ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis

✍ M. Derbala; A. Amer; A. Bener; A. C. Lopez; M. Omar; M. El Ghannam 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

982 Pegylated interferon alfa-2B in comb

982 Pegylated interferon alfa-2B in combination with ribavirin for the treatment of chronic hepatitis C genotype 4

✍ HASAN, F; ASKER, H; ALKHALDI, J; SIDDIQUE, I; OWAID, S; ALAJMI, M; ALNAKIB, B 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Outcome of Treatment With Pegylated Inte

Outcome of Treatment With Pegylated Interferon and Ribavirin in Heart Transplant Recipients With Chronic Hepatitis C

✍ E. Durante-Mangoni; E. Ragone; D. Pinto; D. Iossa; F.E. Covino; C. Maiello; R. U 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 695 KB